Abstract
Objective: DSM‐5 prohibits the diagnosis of avoidant/restrictive food intake disorder (ARFID) in the context of clinically significant shape/weight concerns. However, emerging data suggest that ARFID and shape/weight concerns may co‐occur, and DSM‐5‐TR now permits comorbid binge‐eating disorder alongside ARFID. We compared shape/weight concerns in adults with ARFID to healthy controls (HCs) and nonclinical norms; assessed the frequency of clinical‐level shape/weight concerns and past‐month objective binge episodes (OBE); and identified ARFID characteristics linked to elevated shape/weight concerns and OBEs. We hypothesized that individuals with ARFID would exhibit lower shape/weight concerns than HCs and nonclinical norms, that none would exhibit clinical‐level shape/weight concerns, and that higher weight would predict greater shape/weight concerns. Our examination of OBEs was exploratory.Method: Participants with ARFID (N = 83) and HCs (N = 41) completed the Eating Disorder Examination—Questionnaire (EDE‐Q).Results: Adults with ARFID scored significantly higher than HCs but significantly lower than nonclinical norms on shape/weight concerns. Two percent exhibited clinical‐level shape/weight concerns, and 15% reported past‐month OBEs. Higher weight uniquely predicted shape/weight concerns.Discussion: Shape/weight concerns are lower in ARFID than in the general population, and a small proportion of adults with ARFID—particularly those at higher weights—may experience clinical‐level shape/weight concerns and OBEs.
Funding Information
  • National Institute of Mental Health (K23MH125143, K23MH127465, K24MH120568, K24MH135189, R01MH108595, R01MH128246, 1UL1TR002541‐01)

This publication has 25 references indexed in Scilit: